Jennifer Härdfeldt

Dr. Jennifer Härdfeldt

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PSPeter Saliba-Gustafsson
Peter Saliba-Gustafsson
JHJennifer Härdfeldt
Jennifer Härdfeldt
MPMatteo Pedrelli
Matteo Pedrelli
PPPaolo Parini
Paolo Parini
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver condition globally, driven by strong genetic and environmental components. This review summarizes recent advances in understanding the genetic architecture of MASLD. Genome-wide association studies (GWAS) have identified several key risk variants, primarily in genes such as PNPLA3, TM6SF2, GCKR, and MBOAT7, which influence hepatic lipid metabolism and disease progression. By utilizing surrogate markers of MASLD, researchers have also identified numerous putative MASLD-associated genes, warranting further investigation through functional genomics approaches. Next-generation sequencing techniques have uncovered rare variants in genes like APOB and ABCB4, as well as protective variants in HSD17B13 and CIDEB. This review discusses the potential of polygenic risk scores for disease stratification and the development of genetically informed therapeutic strategies. Additionally, it explores the future of functional genomics approaches in discovering novel treatment strategies. While the evolving genetic landscape of MASLD provides promising insights for precision medicine approaches in diagnosis, prognosis, and treatment, significant translational gaps remain. Addressing these challenges will be critical for realizing the full potential of personalised approaches in clinical management. This review synthesizes these findings and discusses their implications for future research and clinical practice in MASLD.

1 August 2021 in Atherosclerosis
Verified
Journal Article
Closed access
PDF file
SSSara Straniero
Sara Straniero
ALA. Laskar
A. Laskar
CSC. Savva
C. Savva
JHJennifer Härdfeldt
Jennifer Härdfeldt
BAB. Angelin
B. Angelin
MRM. Rudling
M. Rudling

23 March 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
LCLin Chen
Lin Chen
ZKZhanfang Kang
Zhanfang Kang
JHJennifer Härdfeldt
Jennifer Härdfeldt
ZLZiyi Li
Ziyi Li
MPMatteo Pedrelli
Matteo Pedrelli
RFRongrong Fan
Rongrong Fan
The liver is a central organ controlling lipid and cholesterol metabolism and plays a key role in regulating lipoprotein profiles and cardiovascular disease risk. Males and females show clear differences in cholesterol handling and susceptibility to atherosclerosis, but the molecular basis for these sex-specific effects remains incompletely understood. Here we show that the X-linked histone demethylase 6 A (KDM6A) is essential for maintaining healthy cholesterol metabolism in the liver. Reducing KDM6A levels in human liver cells from females but not males disrupts gene programs involved in lipoprotein regulation linked to cardiovascular disorders. Consistently, female mice lacking KDM6A specifically in hepatocytes develops pro-atherogenic blood lipoprotein profiles and increased atherosclerosis under genetic and dietary stress, whereas males are largely unaffected. Mechanistically, KDM6A cooperates with Hepatocyte Nuclear Factor 4 Alpha (HNF4A) to promote chromatin activation and enable CREBH (encoded by CREB3L3)-dependent transcription of lipid metabolic genes. These findings identify KDM6A as a sex-linked regulator of hepatic cholesterol metabolism.

26 March 2026 in JCI Insight
Verified
Journal Article
Open access
PDF file
PBPär Björklund
Pär Björklund
JHJennifer Härdfeldt
Jennifer Härdfeldt
LÄLauri Äikäs
Lauri Äikäs
SSSara Straniero
Sara Straniero
MHMinna Holopainen
Minna Holopainen
BABo Angelin
Bo Angelin
Subendothelial retention of cholesterol-rich apolipoprotein-B–containing lipoproteins drives atherosclerotic arterial disease. In peripheral interstitial fluid from patients with type 2 diabetes (T2D), levels of such particles have been shown to be paradoxically reduced relative to those in serum, presumably reflecting their increased retention within the arterial wall. To identify possible mechanisms involved in lipoprotein retention in T2D, we obtained serum and skin blister fluid from such patients and matched controls, together with skin biopsies in a subset of individuals. In T2D, smaller LDL and VLDL remnant particles were more prominent in serum but not in interstitial fluid, reflecting their enhanced vascular entrapment. The interstitial-fluid-to-serum ratio of apolipoprotein-B was 58% lower in T2D than in controls (0.14 versus 0.33), concomitant with increased susceptibility for LDL binding to proteoglycans. The most marked differences were seen in patients with clinically evident cardiovascular disease. The degree of transvascular retention was positively related to the propensity of isolated serum LDL to bind aortic proteoglycans, both in T2D and in controls. Skin unesterified cholesterol levels were higher in patients with T2D relative to healthy controls. With aging, both proteoglycan binding and apparent vascular retention of LDL increased in controls but not in T2D, indicating that these mechanisms may also be relevant for atherogenesis in nondiabetic individuals.

5 January 2026 in Research Square
Verified
Preprint
Open access
PDF file
RFRongrong Fan
Rongrong Fan
LCLin Chen
Lin Chen
ZKZhanfang Kang
Zhanfang Kang
JHJennifer Härdfeldt
Jennifer Härdfeldt
ZLZiyi Li
Ziyi Li
ETEckardt Treuter
Eckardt Treuter
The liver is a central organ in the maintenance of lipid metabolism. It coordinates cholesterol uptake, biosynthesis, excretion and clearance through an intricated transcription network defined in the epigenetic level by transcription factors and coregulators. Those networks differ between males and females, resulting in marked sex differences in lipoprotein patterns and risk of developing atherosclerosis. How sex chromosome-linked epigenetic modulators contribute to such sex-specific metabolism remains unclarified. Here, we have demonstrated that the X- linked histone demethylase 6A (KDM6A) is a crucial coregulator involved in liver cholesterol regulation. KDM6A knockdown in human liver cells induces transcriptional changes annotated to lipoprotein and cholesterol metabolic pathways linked with cardiovascular disorders. Consistently, hepatocyte specific KDM6A knockout (LKO) female, but not male, mice display substantial atherogenic circulating lipoprotein profiles and are prone to developing atherosclerosis upon genetic and dietary challenges. Mechanistically, KDM6A is recruited to chromatin by Hepatic Nuclear Factor 4 Alpha (HNF4A). This creates an active epigenetic microenvironment essential for the binding of cAMP-responsive element-binding protein H (CREBH, encoded by CREB3L3), which subsequently activates the transcription of lipoprotein and cholesterol metabolic genes in hepatocytes. Therefore, our study uncovers a novel mechanistic link of KDM6A with atherosclerosis using both human cell and mouse models. Because KDM6A is an X-inactivation ‘escapee’ with higher expression in female than male hepatocytes, it may contribute to the sex dimorphism of cholesterol metabolism and cardiovascular risk.

24 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
EBEmelie Barreby
Emelie Barreby
FDFederica D&Apos;Annunzio
Federica D&Apos;Annunzio
JHJennifer Härdfeldt
Jennifer Härdfeldt
DCDavide Capozzi
Davide Capozzi
Giulia FisconGiulia Fiscon
Giulia Fiscon
CMCecilia Morgantini
Cecilia Morgantini
Diabetic foot ulcers frequently fail to heal despite multidisciplinary care, yet the systemic immune trajectories associated with healing remain poorly defined. We profiled longitudinal plasma samples from adults with diabetic foot ulcers using targeted proteomics and single-cell RNA sequencing profiles of peripheral blood mononuclear cells at ulcer presentation. Protein co-expression network analysis identified an early module enriched for chemokine-mediated leukocyte recruitment that was positively associated with subsequent healing. At later visits, healing-associated modules shifted toward innate immune activation and vascular/tissue-remodeling programs. Network prioritization highlighted CCL4 as an early candidate marker of the healing-associated inflammatory module. Although CCL4 transcripts were sparsely detected in circulating immune cells, patients who subsequently healed showed increased expression of CCL4-responsive receptors, including CCR1 in monocytes and CCR5 in cytotoxic γδ T cells, suggesting enhanced responsiveness to an extrinsic chemokine signal. Integration with published wound single-cell atlases identified monocyte/macrophage populations as plausible local sources of CCL4. These exploratory data support a model in which successful diabetic foot ulcer repair is associated with a coordinated early inflammatory recruitment program followed by reparative remodeling, and provide candidate circulating modules for validation in larger cohorts